6,678 trials
Partial Epilepsy
Primary: Change in Epworth Sleepiness Scale Score From Baseline to Visit 4 — -1.2; -1.1 Units on a scale — p=0.027
Posttraumatic Stress Disorder
Primary: Change From Baseline in Clinical Administered PTSD Scale (CAPS) Total — -39 units on a scale — p=<.0001
Postmenopausal Osteoporosis
Primary: Bone Turnover Marker (Blood Sample) — -7; 43 percentage of change in CTX
Analysis, Event History · Absorption; Disorder, Protein
Primary: Weekly Blood Draws to Measure Blood Protein Levels — 7.23; 6.86; 7.43; 7.21 grams per deciliter
Hepatitis B · Tetanus · Poliomyelitis
Primary: Number of Seroprotected Subjects Against Polyribosyl-ribitol Phosphate (Anti-PRP) — 92; 106 Subjects
Anxiety Disorders
Primary: Hamilton Rating Scale for Anxiety — 4.17; 6.29; 11.35; 5.80 HAM-A Rating Score
ADHD · Stimulant-Induced Euphoria
Primary: Change in Score on AISRS From Baseline to Week 6 — -26.7; -29.1 units on a scale
Atrial Fibrillation
Primary: Pre-dose Concentration of the Analyte in Plasma at Steady State Immediately Before Administration of the Next Dose — 155 ng/mL
HIV Infection · Hepatitis C
Primary: HCV RNA — 0.65; 0.81 log IU/ml
Influenza · Healthy
Primary: Percentage of Participants With Fever Greater Than or Equal to (>=) 101 Degrees Fahrenheit (F) — 0; 0.4 Percentage of Participant
Venous Stasis Ulcers
Primary: Matrix Metalloproteinase Level in Wound Fluid — 0.71; 0.88 mcg/ml
Major Depression · Irritable Bowel Syndrome
Primary: Montgomery-Asberg Depression Rating Scale (MADRS) — 31.59; 15.67; 11.4 units on a scale — p=<.05
Attention Deficit Hyperactivity Disorder
Primary: Attention Deficit Hyperactivity Disorder- Rating Scale (ADHS-RS) — 13.9 units on a scale — p=0.001
Chronic Phase Chronic Myeloid Leukemia
Primary: The Number of Imatinib-related Adverse Events (AEs) That Were Resolved, Improved, Remained Unchanged, or Worsened After 3 Months of Dasatinib Treatment — 91; 2; 27; 1…
Hepatitis C
Primary: Percentage of Participants Who Achieve Sustained Virological Response at Follow-up Week 24 (SVR24) — 35.2 Percentage of participants